Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy

NCT01469013 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Placebo
DRUG: Baricitinib
DRUG: Baricitinib
DRUG: Baricitinib
DRUG: Methotrexate

Sponsor

Eli Lilly and Company